Regeneron's Q3 earnings beat forecasts as strong Dupixent profits and rising Eylea HD sales offset a decline in its flagship Eylea brand.

Alphonse Rudakubana, 49, said his family expected a 'high degree of confidentiality' and did not want those 'in charge of ...

Gazyva/Gazyvaro versus mycophenolate mofetil shows significantly more children and young adults achieved sustained complete ...